Operating Lease, Liability of Can-Fite BioPharma Ltd. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Can-Fite BioPharma Ltd. quarterly Operating Lease, Liability in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • Can-Fite BioPharma Ltd. Operating Lease, Liability for the quarter ending 31 Dec 2024 was $104,000, a 160% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $104,000 +$64,000 +160% 31 Dec 2024 20-F 14 Apr 2025 2024 FY
Q4 2023 $40,000 -$22,000 -35% 31 Dec 2023 20-F 28 Mar 2024 2023 FY
Q4 2022 $62,000 -$62,000 -50% 31 Dec 2022 20-F 30 Mar 2023 2022 FY
Q4 2021 $124,000 +$57,000 +85% 31 Dec 2021 20-F 24 Mar 2022 2021 FY
Q4 2020 $67,000 -$8,000 -11% 31 Dec 2020 20-F 25 Mar 2021 2020 FY
Q4 2019 $75,000 31 Dec 2019 6-K 01 Jun 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.